Nova Patents
ATE229799T1

Improvements in medicaments for asthma treatment

Abstract

A method and apparatus are disclosed for treating asthma and other respiratory conditions. A medicament comprising a surface active phospholipid (SAPL) is prepared in the form of a fine powder and administered to the lungs in a gas stream. A preferred SAPL is a solid blend of diplamitoyl choline and phosphatdiyl glycerol (PG).

Term

Term ended

Projected expiry passed 26 November 2018, 7.8 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

34 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
DocumentOfficeKindDate
9725640United KingdomA
9727276United KingdomA
9803543United KingdomW

Members34

Family members, oldest first
DocumentOfficeKind
GB9725640D0United KingdomD0
GB9727276D0United KingdomD0
GB9825972D0United KingdomD0
GB2331925AUnited KingdomA
WO9927920A2World Intellectual Property Organization (WIPO)A2
AU1251999AAustraliaA
GB9912639D0United KingdomD0
WO9927920A3World Intellectual Property Organization (WIPO)A3
WO0030654A1World Intellectual Property Organization (WIPO)A1
AU1287800AAustraliaA
EP1082108A2European Patent Office (EPO)A2
GB0114529D0United KingdomD0
GB2359749AUnited KingdomA
EP1133301A1European Patent Office (EPO)A1
GB2331925A9United KingdomA9
JP2002530344AJapanA
US6482391B1United States of AmericaB1
EP1082108B1European Patent Office (EPO)B1
AT229799TAustriaT
ATE229799T1This recordAustriaT1
DK1082108T3DenmarkT3
DE69810355D1GermanyD1
US2003044357A1United States of AmericaA1
ES2189269T3SpainT3
DE69810355T2GermanyT2
GB2359749BUnited KingdomB
US6824761B1United States of AmericaB1
US2005063910A1United States of AmericaA1
US2005080052A1United States of AmericaA1
EP1658851A1European Patent Office (EPO)A1
JP2006199713AJapanA
JP3840515B2JapanB2
US7273604B2United States of AmericaB2
US7473416B2United States of AmericaB2